An anti-Covid vaccine jointly developed by Pfizer and BioNTech was found to be effective in preventing 90 percent of infections during Phase 3 of the trial, which is still ongoing.
This was announced by Pfizer president Albert Bourla.
Pfizer, our 90% effective anti-Covid vaccine
2020-11-09T12:48:06.285Z
- France's Pharmacists Launch Massive Strike Over Financial Challenges and Drug Shortages
- Boost Your Memory: Brain-Challenging Exercises and Lifestyle Tips to Reduce Dementia Risk
- New Caledonia Unrest and Global Tensions: Multiple Tragedies Amidst Rising Concerns
- How FLiRT Variants are Changing the Covid-19 Landscape: Key Insights
An anti-Covid vaccine jointly developed by Pfizer and BioNTech was found to be effective in preventing 90 percent of infections during Phase 3 of the trial, which is still ongoing. This was announced by Pfizer president Albert Bourla. (HANDLE)
Similar news:
- Covid-19: Pfizer announces that its vaccine is "90% effective", according to preliminary results 4 years
- Pfizer announces: 'Our Covid vaccine is 90% effective' 4 years
- A vaccine that is 90% effective: four questions about Pfizer's shocking announcement 4 years
- Covid: Moscow, our Sputnik vaccine 92% effective 4 years
- Covid: Moscow, our Sputnik vaccine 92% effective 4 years